Scale Biosciences: Giovanna Prout, Jackie Fidanza, John Hu, Scott McCuine
Scale Biosciences, a developer of single-cell sequencing products, recently expanded its executive leadership team, naming Giovanna Prout as CEO, Jackie Fidanza as chief operating officer, John Hu as VP of finance, and Scott McCuine as VP of business development.
Prout was previously VP of marketing at Deepcell. Before that she held marketing and commercial leadership roles of increasing responsibility at 10x Genomics and Illumina. She holds a BS in engineering and an MBA from the University of California, San Diego.
Fidanza joins Scale from Twist Bioscience, where she most recently held the role of VP of operations. Before that she served as VP of manufacturing and senior director of manufacturing at Twist. Fidanza has also served as a leader of R&D/operations at Thermo Fisher Scientific. She holds a BS and PhD in chemistry from Boston College.
Hu previously served as VP of finance for IonPath, director of finance for Coherent, and director of FP&A and treasury at Reliant Technologies. He has also previously served as finance manager in business development and marketing for Roche Molecular Systems. Hu has an MBA from UC, Berkeley, and an MS in chemistry from the University of Miami.
McCuine also joins Scale from Twist Bioscience, where he most recently served as director of business development. Prior to that, he was senior business development manager for next-generation sequencing and senior sales manager, Americas, for NGS at Twist. McCuine has also been a genomics product specialist at Agilent Technologies. He holds an MBA from the Babson F.W. Olin Graduate School of Business and a BS in biochemistry and genetics from Texas A&M University.